SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-022409
Filing Date
2024-06-03
Accepted
2024-06-03 17:09:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 defa-14a.htm DEFA14A 171550
2 defa-14a_001.jpg GRAPHIC 5547
  Complete submission text file 0001493152-24-022409.txt   180418
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36357 | Film No.: 241014705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)